The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Jazz Pharmaceuticals (I)
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Sanofi (Inst)
Expert Testimony - Abbvie; Allergan
Real-world outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving second-line (2L) chemotherapy (CT) vs alternative androgen receptor-targeted agents (ARTA) after lack of response to first-line (1L) ARTA in US community oncology practices.
 
William K. Oh
Leadership - checkpoint Sciences
Stock and Other Ownership Interests - Bellicum Pharmaceuticals; MDAgree
Consulting or Advisory Role - AstraZeneca; Churchill Pharmaceuticals; Dendreon; Ferring; Inovio Pharmaceuticals; Janssen; Sanofi; Seagen; Teva; Tokai Pharmaceuticals
Research Funding - Astellas Pharma (Inst); Sotio (Inst)
 
Wendy Y. Cheng
Research Funding - GlaxoSmithKline (Inst); Lundbeck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Raymond Miao
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Francis Vekeman
Stock and Other Ownership Interests - Valeant Pharmaceuticals International
Research Funding - Sanofi (Inst)
 
Marjolaine Gauthier-Loiselle
Research Funding - Sanofi (Inst)
 
Mei Sheng Duh
No Relationships to Disclose
 
Edward Drea
Employment - Sanofi; Sanofi (I)
Stock and Other Ownership Interests - Sanofi; Sanofi (I)
 
Ted P. Szatrowski
Employment - Sanofi
Stock and Other Ownership Interests - Roche; Sanofi
Consulting or Advisory Role - EMD Serono (I); Janssen (I); Lilly (I)